Etfbkmttm1(KOMP)Wtsi
Targeted Allele Detail
|
Symbol: |
Etfbkmttm1(KOMP)Wtsi |
Name: |
electron transfer flavoprotein beta subunit lysine methyltransferase; targeted mutation 1, Wellcome Trust Sanger Institute |
MGI ID: |
MGI:4363123 |
Gene: |
Etfbkmt Location: Chr6:149042980-149052669 bp, + strand Genetic Position: Chr6, 78.8 cM
|
IMPC: |
Etfbkmt gene page |
|
Mutant Cell Lines: |
EPD0272_4_A06, EPD0272_4_D06, EPD0272_4_E05, EPD0272_4_E06, EPD0272_4_F07, EPD0272_4_F08, EPD0272_4_H07 |
Germline Transmission: |
Unknown
|
Parent Cell Line: |
JM8A1.N3 (ES Cell)
|
Strain of Origin: |
C57BL/6N-Atm1Brd
|
Project Collection: |
KOMP-CSD
|
|
Allele Type: |
|
Targeted (Null/knockout, Reporter) |
Mutations: |
|
Insertion, Intragenic deletion
Vector: L1L2_Bact_P
|
|
|
Mutation details: The insertion of the L1L2_Bact_P cassette created a deletion of size 7232 starting at position 149045487 and ending at position 149052719 of Chromosome 6 (Genome Build GRCm39). This deletion results in the removal of functionally critical exon(s). The cassette is composed of an FRT site followed by lacZ sequence and a loxP site. This first loxP site is followed by a neomycin resistance gene under the control of the human beta-actin promoter, SV40 polyA, a second FRT site and a second loxP site.
(J:148605, J:173534)
|
|
|
|
Original: |
J:148605 Wellcome Trust Sanger Institute, Alleles produced for the KOMP project by the Wellcome Trust Sanger Institute. MGI Direct Data Submission. 2009; |
All: |
2 reference(s) |
|